Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.08% is in line with its 5-year average of 3.82%, around the middle of its 5-year range (2.20%–5.44%).
36.68% above its 12-month average of 2.99%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 1.06%.
RETURN ON ASSETS (ROA)
4.08%
RETURN ON ASSETS (ROA) AVG TTM
2.99%
RETURN ON ASSETS (ROA) AVG 3Y
3.50%
RETURN ON ASSETS (ROA) AVG 5Y
3.82%
RETURN ON ASSETS (ROA) AVG 10Y
3.49%
RETURN ON ASSETS (ROA) AVG 15Y
3.19%
RETURN ON ASSETS (ROA) AVG 20Y
3.16%
CURRENT VS TTM AVG
+36.68%
CURRENT VS 3Y AVG
+16.49%
CURRENT VS 5Y AVG
+6.81%
CURRENT VS 10Y AVG
+17.00%
CURRENT VS 15Y AVG
+27.90%
CURRENT VS 20Y AVG
+29.20%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-20.62%
vs the sector median at left
Cigna Corporation
Market Cap
$73.88B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
Market Cap
$80.32B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
Market Cap
$64.29B
Return on Assets (ROA)
8.11%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
Market Cap
$62.00B
Return on Assets (ROA)
-28.75%
TTM Avg
-24.02%
3Y Avg
-10.32%
5Y Avg
-0.33%
Market Cap
$90.08B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$92.84B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$53.86B
Return on Assets (ROA)
2.99%
TTM Avg
2.96%
3Y Avg
2.15%
5Y Avg
1.30%
Market Cap
$51.24B
Return on Assets (ROA)
7.25%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cigna Corporation (CI) | $73.88B | 4.08% | 2.99% | 3.50% | 3.82% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.32B | 10.37% | 11.40% | 12.40% | 16.97% |
| Boston Scientific Corporation (BSX)vs › | $64.29B | 8.11% | 5.66% | 4.50% | 3.49% |
| Moderna, Inc. (MRNA)vs › | $62.00B | -28.75% | -24.02% | -10.32% | -0.33% |
| Cencora, Inc. (COR)vs › | $61.51B | 3.13% | 2.14% | 2.52% | 0.85% |
| Elevance Health Inc. (ELV)vs › | $90.08B | 3.93% | 4.89% | 5.25% | 5.41% |
| HCA Healthcare, Inc. (HCA)vs › | $92.84B | 11.30% | 10.43% | 10.23% | 10.42% |
| Cardinal Health, Inc. (CAH)vs › | $53.86B | 2.99% | 2.96% | 2.15% | 1.30% |
| Edwards Lifesciences Corporation (EW)vs › | $51.24B | 7.25% | 19.91% | 18.29% | 17.04% |
| Becton, Dickinson and Company (BDX)vs › | $50.41B | 1.85% | 3.00% | 3.04% | 2.95% |
ROA
4.1%
ROE
15.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.77% |
| 2024-12-31 | 2.20% |
| 2023-12-31 | 3.38% |
| 2022-12-31 | 4.66% |
| 2021-12-31 | 3.47% |
| 2020-12-31 | 5.44% |
| 2019-12-31 | 3.28% |
| 2018-12-31 | 1.72% |
| 2017-12-31 | 3.62% |
| 2016-12-31 | 3.15% |
| 2015-12-31 | 3.67% |
| 2014-12-31 | 3.76% |
| 2013-12-31 | 2.72% |
| 2012-12-31 | 3.18% |
| 2011-12-31 | 2.47% |
| 2010-12-31 | 2.80% |
| 2009-12-31 | 3.03% |
| 2008-12-31 | 0.71% |
| 2007-12-31 | 2.78% |
| 2006-12-31 | 2.72% |
| 2005-12-31 | 3.62% |
| 2004-12-31 | 1.77% |
| 2003-12-31 | 0.69% |
| 2002-12-31 | -0.50% |
| 2001-12-31 | 1.03% |
| 2000-12-31 | 0.99% |
| 1999-12-31 | 1.86% |
| 1998-12-31 | 1.13% |
| 1997-12-31 | 1.00% |
| 1996-12-31 | 1.07% |
